Sr One Capital Management, LP has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $435 Million distributed in 12 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $193M, Crispr Therapeutics Ag with a value of $132M, Oric Pharmaceuticals, Inc. with a value of $53.9M, Design Therapeutics, Inc. with a value of $49.1M, and Nkarta, Inc. with a value of $6.9M.

Examining the 13F form we can see an increase of $156M in the current position value, from $279M to 435M.

Below you can find more details about Sr One Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $435 Million
Healthcare: $435 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 12
  • Current Value $435 Million
  • Prior Value $279 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 12, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Sr One Capital Management, LP Portfolio

Follow Sr One Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sr One Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sr One Capital Management, LP with notifications on news.